20
Apicore Pharmaceuticals Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PENICILLAMINE, USP, with a corresponding US DMF Number 30993.
Remarkably, this DMF maintains an Active status since its submission on October 18, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 19, 2017, and payment made on September 28, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II